{"id":"https://openalex.org/W4393076472","doi":"https://doi.org/10.1158/1538-7445.am2024-5820","title":"Abstract 5820: An antibody drug conjugate platform based on novel camptothecin payloads with branch hydrophilic linkers and site-specific conjugation","display_name":"Abstract 5820: An antibody drug conjugate platform based on novel camptothecin payloads with branch hydrophilic linkers and site-specific conjugation","publication_year":2024,"publication_date":"2024-03-22","ids":{"openalex":"https://openalex.org/W4393076472","doi":"https://doi.org/10.1158/1538-7445.am2024-5820"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2024-5820","doi":"https://doi.org/10.1158/1538-7445.am2024-5820","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1158/1538-7445.am2024-5820","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100610147","display_name":"Yuanyuan Huang","orcid":"https://orcid.org/0000-0003-0101-4941","observed_orcids":["https://orcid.org/0000-0003-0101-4941"]},"institutions":[{"id":"https://openalex.org/I4210142178","display_name":"Hangzhou DAC Biotech (China)","ror":"https://ror.org/04hy71c73","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210142178"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yuanyuan Huang","raw_affiliation_strings":["1Hangzhou DAC Biotechnology Co., Ltd., Hangzhou City, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Hangzhou DAC Biotechnology Co., Ltd., Hangzhou City, China","institution_ids":["https://openalex.org/I4210142178"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045398637","display_name":"Hangbo Ye","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210142178","display_name":"Hangzhou DAC Biotech (China)","ror":"https://ror.org/04hy71c73","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210142178"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Hangbo Ye","raw_affiliation_strings":["1Hangzhou DAC Biotechnology Co., Ltd., Hangzhou City, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Hangzhou DAC Biotechnology Co., Ltd., Hangzhou City, China","institution_ids":["https://openalex.org/I4210142178"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004242661","display_name":"Qingliang Yang","orcid":"https://orcid.org/0000-0002-6905-8484","observed_orcids":["https://orcid.org/0000-0002-6905-8484"]},"institutions":[{"id":"https://openalex.org/I4210142178","display_name":"Hangzhou DAC Biotech (China)","ror":"https://ror.org/04hy71c73","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210142178"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Qingliang Yang","raw_affiliation_strings":["1Hangzhou DAC Biotechnology Co., Ltd., Hangzhou City, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Hangzhou DAC Biotechnology Co., Ltd., Hangzhou City, China","institution_ids":["https://openalex.org/I4210142178"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100603191","display_name":"Lingli Zhang","orcid":"https://orcid.org/0000-0003-3316-010X","observed_orcids":["https://orcid.org/0000-0003-3316-010X"]},"institutions":[{"id":"https://openalex.org/I4210142178","display_name":"Hangzhou DAC Biotech (China)","ror":"https://ror.org/04hy71c73","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210142178"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Lingli Zhang","raw_affiliation_strings":["1Hangzhou DAC Biotechnology Co., Ltd., Hangzhou City, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Hangzhou DAC Biotechnology Co., Ltd., Hangzhou City, China","institution_ids":["https://openalex.org/I4210142178"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101688743","display_name":"Huihui Guo","orcid":"https://orcid.org/0000-0002-0848-0585","observed_orcids":["https://orcid.org/0000-0002-0848-0585"]},"institutions":[{"id":"https://openalex.org/I4210142178","display_name":"Hangzhou DAC Biotech (China)","ror":"https://ror.org/04hy71c73","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210142178"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Huihui Guo","raw_affiliation_strings":["1Hangzhou DAC Biotechnology Co., Ltd., Hangzhou City, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Hangzhou DAC Biotechnology Co., Ltd., Hangzhou City, China","institution_ids":["https://openalex.org/I4210142178"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100442737","display_name":"Xiaolei Liu","orcid":"https://orcid.org/0000-0001-8262-0876","observed_orcids":["https://orcid.org/0000-0001-8262-0876"]},"institutions":[{"id":"https://openalex.org/I4210142178","display_name":"Hangzhou DAC Biotech (China)","ror":"https://ror.org/04hy71c73","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210142178"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Xiaolei Liu","raw_affiliation_strings":["1Hangzhou DAC Biotechnology Co., Ltd., Hangzhou City, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Hangzhou DAC Biotechnology Co., Ltd., Hangzhou City, China","institution_ids":["https://openalex.org/I4210142178"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100446244","display_name":"Wenjun Li","orcid":"https://orcid.org/0000-0001-5335-7386","observed_orcids":["https://orcid.org/0000-0001-5335-7386"]},"institutions":[{"id":"https://openalex.org/I4210142178","display_name":"Hangzhou DAC Biotech (China)","ror":"https://ror.org/04hy71c73","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210142178"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Wenjun Li","raw_affiliation_strings":["1Hangzhou DAC Biotechnology Co., Ltd., Hangzhou City, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Hangzhou DAC Biotechnology Co., Ltd., Hangzhou City, China","institution_ids":["https://openalex.org/I4210142178"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Lu Bai","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210142178","display_name":"Hangzhou DAC Biotech (China)","ror":"https://ror.org/04hy71c73","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210142178"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Lu Bai","raw_affiliation_strings":["1Hangzhou DAC Biotechnology Co., Ltd., Hangzhou City, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Hangzhou DAC Biotechnology Co., Ltd., Hangzhou City, China","institution_ids":["https://openalex.org/I4210142178"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110878316","display_name":"Junxiang Jia","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210142178","display_name":"Hangzhou DAC Biotech (China)","ror":"https://ror.org/04hy71c73","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210142178"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Junxiang Jia","raw_affiliation_strings":["1Hangzhou DAC Biotechnology Co., Ltd., Hangzhou City, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Hangzhou DAC Biotechnology Co., Ltd., Hangzhou City, China","institution_ids":["https://openalex.org/I4210142178"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5115595437","display_name":"Juan Wang","orcid":"https://orcid.org/0000-0002-5023-5081","observed_orcids":["https://orcid.org/0000-0002-5023-5081"]},"institutions":[{"id":"https://openalex.org/I4210142178","display_name":"Hangzhou DAC Biotech (China)","ror":"https://ror.org/04hy71c73","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210142178"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Juan Wang","raw_affiliation_strings":["1Hangzhou DAC Biotechnology Co., Ltd., Hangzhou City, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Hangzhou DAC Biotechnology Co., Ltd., Hangzhou City, China","institution_ids":["https://openalex.org/I4210142178"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103132538","display_name":"Xiangfei Kong","orcid":"https://orcid.org/0000-0003-2422-6189","observed_orcids":["https://orcid.org/0000-0003-2422-6189"]},"institutions":[{"id":"https://openalex.org/I4210142178","display_name":"Hangzhou DAC Biotech (China)","ror":"https://ror.org/04hy71c73","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210142178"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Xiangfei Kong","raw_affiliation_strings":["1Hangzhou DAC Biotechnology Co., Ltd., Hangzhou City, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Hangzhou DAC Biotechnology Co., Ltd., Hangzhou City, China","institution_ids":["https://openalex.org/I4210142178"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100934235","display_name":"Jun Zheng","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210142178","display_name":"Hangzhou DAC Biotech (China)","ror":"https://ror.org/04hy71c73","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210142178"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Jun Zheng","raw_affiliation_strings":["1Hangzhou DAC Biotechnology Co., Ltd., Hangzhou City, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Hangzhou DAC Biotechnology Co., Ltd., Hangzhou City, China","institution_ids":["https://openalex.org/I4210142178"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101321771","display_name":"Yifang Xu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210142178","display_name":"Hangzhou DAC Biotech (China)","ror":"https://ror.org/04hy71c73","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210142178"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yifang Xu","raw_affiliation_strings":["1Hangzhou DAC Biotechnology Co., Ltd., Hangzhou City, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Hangzhou DAC Biotechnology Co., Ltd., Hangzhou City, China","institution_ids":["https://openalex.org/I4210142178"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5105791591","display_name":"Gengxiang Zhao","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210142178","display_name":"Hangzhou DAC Biotech (China)","ror":"https://ror.org/04hy71c73","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210142178"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Gengxiang Zhao","raw_affiliation_strings":["1Hangzhou DAC Biotechnology Co., Ltd., Hangzhou City, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Hangzhou DAC Biotechnology Co., Ltd., Hangzhou City, China","institution_ids":["https://openalex.org/I4210142178"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048176520","display_name":"Linyao Zhao","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210142178","display_name":"Hangzhou DAC Biotech (China)","ror":"https://ror.org/04hy71c73","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210142178"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Linyao Zhao","raw_affiliation_strings":["1Hangzhou DAC Biotechnology Co., Ltd., Hangzhou City, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Hangzhou DAC Biotechnology Co., Ltd., Hangzhou City, China","institution_ids":["https://openalex.org/I4210142178"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102707561","display_name":"Xiang Cai","orcid":"https://orcid.org/0000-0001-7265-6867","observed_orcids":["https://orcid.org/0000-0001-7265-6867"]},"institutions":[{"id":"https://openalex.org/I4210142178","display_name":"Hangzhou DAC Biotech (China)","ror":"https://ror.org/04hy71c73","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210142178"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Xiang Cai","raw_affiliation_strings":["1Hangzhou DAC Biotechnology Co., Ltd., Hangzhou City, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Hangzhou DAC Biotechnology Co., Ltd., Hangzhou City, China","institution_ids":["https://openalex.org/I4210142178"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Ziyu Zhao","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210142178","display_name":"Hangzhou DAC Biotech (China)","ror":"https://ror.org/04hy71c73","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210142178"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Ziyu Zhao","raw_affiliation_strings":["1Hangzhou DAC Biotechnology Co., Ltd., Hangzhou City, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Hangzhou DAC Biotechnology Co., Ltd., Hangzhou City, China","institution_ids":["https://openalex.org/I4210142178"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Hui Xia","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210142178","display_name":"Hangzhou DAC Biotech (China)","ror":"https://ror.org/04hy71c73","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210142178"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Hui Xia","raw_affiliation_strings":["1Hangzhou DAC Biotechnology Co., Ltd., Hangzhou City, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Hangzhou DAC Biotechnology Co., Ltd., Hangzhou City, China","institution_ids":["https://openalex.org/I4210142178"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113437758","display_name":"Xia Zhou","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210142178","display_name":"Hangzhou DAC Biotech (China)","ror":"https://ror.org/04hy71c73","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210142178"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Xia Zhou","raw_affiliation_strings":["1Hangzhou DAC Biotechnology Co., Ltd., Hangzhou City, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Hangzhou DAC Biotechnology Co., Ltd., Hangzhou City, China","institution_ids":["https://openalex.org/I4210142178"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100761588","display_name":"You Zhou","orcid":"https://orcid.org/0000-0001-9250-0982","observed_orcids":["https://orcid.org/0000-0001-9250-0982"]},"institutions":[{"id":"https://openalex.org/I4210142178","display_name":"Hangzhou DAC Biotech (China)","ror":"https://ror.org/04hy71c73","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210142178"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"You Zhou","raw_affiliation_strings":["1Hangzhou DAC Biotechnology Co., Ltd., Hangzhou City, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Hangzhou DAC Biotechnology Co., Ltd., Hangzhou City, China","institution_ids":["https://openalex.org/I4210142178"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5100871949","display_name":"Robert Yongxin Zhao","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210142178","display_name":"Hangzhou DAC Biotech (China)","ror":"https://ror.org/04hy71c73","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210142178"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Robert Y. Zhao","raw_affiliation_strings":["1Hangzhou DAC Biotechnology Co., Ltd., Hangzhou City, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Hangzhou DAC Biotechnology Co., Ltd., Hangzhou City, China","institution_ids":["https://openalex.org/I4210142178"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210142178"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"84","issue":"6_Supplement","first_page":"5820","last_page":"5820"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.9140999913215637,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.9140999913215637,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.042100001126527786,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13105","display_name":"Synthesis and pharmacology of benzodiazepine derivatives","score":0.025299999862909317,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antibody-drug-conjugates","display_name":"antibody-drug conjugates","score":0.9929999709129333},{"id":"https://openalex.org/keywords/camptothecin-analogs","display_name":"camptothecin analogues","score":0.9490000009536743},{"id":"https://openalex.org/keywords/topoisomerase-i-inhibitor","display_name":"topoisomerase I inhibitor","score":0.9419999718666077},{"id":"https://openalex.org/keywords/sn-38","display_name":"SN-38","score":0.7639999985694885},{"id":"https://openalex.org/keywords/site-specific-conjugation","display_name":"site-specific conjugation","score":0.9779999852180481},{"id":"https://openalex.org/keywords/therapeutic-window","display_name":"therapeutic window","score":0.6209999918937683},{"id":"https://openalex.org/keywords/antitumor-efficacy","display_name":"antitumor efficacy","score":0.6570000052452087},{"id":"https://openalex.org/keywords/toxicity","display_name":"toxicity","score":0.40299999713897705},{"id":"https://openalex.org/keywords/trastuzumab-deruxtecan","display_name":"trastuzumab deruxtecan","score":0.7860000133514404},{"id":"https://openalex.org/keywords/sacituzumab-govitecan","display_name":"sacituzumab govitecan","score":0.921999990940094}],"concepts":[{"id":"https://openalex.org/C197336794","wikidata":"https://www.wikidata.org/wiki/Q5161150","display_name":"Conjugate","level":2,"score":0.9047318696975708},{"id":"https://openalex.org/C2779682216","wikidata":"https://www.wikidata.org/wiki/Q419964","display_name":"Camptothecin","level":2,"score":0.8381426334381104},{"id":"https://openalex.org/C2777325958","wikidata":"https://www.wikidata.org/wiki/Q1069596","display_name":"Antibody-drug conjugate","level":4,"score":0.6523666381835938},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.6338766813278198},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.5263040065765381},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.4211216866970062},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.411430686712265},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3328154683113098},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.30488020181655884},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.17786246538162231},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.17189326882362366},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.11201915144920349},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.06075605750083923},{"id":"https://openalex.org/C134306372","wikidata":"https://www.wikidata.org/wiki/Q7754","display_name":"Mathematical analysis","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2024-5820","doi":"https://doi.org/10.1158/1538-7445.am2024-5820","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1158/1538-7445.am2024-5820","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7166554412","https://openalex.org/W4387598951","https://openalex.org/W2163235231","https://openalex.org/W3083189100","https://openalex.org/W3000428852","https://openalex.org/W4393096899","https://openalex.org/W3178947409","https://openalex.org/W4393087530","https://openalex.org/W4391805157","https://openalex.org/W4362534553"],"abstract_inverted_index":{"Abstract":[0],"Antibody-drug":[1],"conjugates":[2],"(ADCs)":[3],"have":[4,89,181],"recently":[5],"gained":[6],"momentum":[7],"as":[8,38,60,72,153,167],"a":[9,51,170,182,223],"therapeutic":[10,44,143,184,341,364],"modality":[11],"for":[12,177,388,462],"the":[13,27,65,99,114,119,162,196,202,211,228,258,269,286,303,334,351,459],"cell-specific":[14],"delivery":[15],"of":[16,23,29,31,121,135,164,199,204,214,227,237,239,272,279,285,302,350,362,385,391,458],"small":[17],"molecules":[18],"beyond":[19],"their":[20,110],"originally-intended":[21],"purpose":[22],"treating":[24],"cancer.":[25],"However,":[26],"selection":[28],"combinations":[30],"an":[32,220,280],"optimum":[33],"target,":[34],"antibody,":[35],"payload,":[36],"linker":[37,173],"well":[39],"conjugation,":[40],"to":[41,118,180,235,383],"achieve":[42],"maximal":[43],"efficacy":[45,315],"without":[46],"excessive":[47],"toxicity,":[48],"still":[49],"presents":[50],"significant":[52],"challenge.":[53],"Topoisomerase":[54],"I":[55,104],"(Topo":[56],"I)":[57],"inhibitors":[58,105],"such":[59,152],"camptothecin":[61,446],"(CPT)":[62],"analogs":[63,193,231],"represent":[64],"much":[66,312],"success":[67],"in":[68,98,127,137,145,242,257,316,327,331,356,359,372],"ADC":[69,335],"payload":[70,81,88],"applications":[71],"two":[73],"CPT":[74,95,165,192,230,287,304],"analog-ADCs,":[75],"trastuzumab":[76],"deruxtecan":[77],"(DS-8201a\u2014Enhertu\u00ae)":[78],"with":[79,86,169,187,208,219,264,290,306,333,337,346,448],"Dxd":[80],"and":[82,92,124,130,155,174,210,250,268,358,375,377,452],"sacituzumab":[83],"govitecan":[84],"(TrodelvyTM)":[85],"SN38":[87],"been":[90],"approved":[91],"over":[93],"20":[94],"analog-ADCs":[96],"are":[97],"clinical":[100,146],"trials":[101,147],"now.":[102],"Topo":[103],"trigger":[106],"cell":[107,131,248],"apoptosis":[108],"through":[109,282,299],"specific":[111],"binding":[112],"at":[113,233,276],"DNA-topoisomerase":[115],"interface,":[116],"leading":[117],"inhibition":[120],"DNA":[122,128],"supercoiling":[123],"entanglement,":[125],"resulting":[126],"damage":[129],"death.":[132],"This":[133],"class":[134],"payloads":[136,168,288,305,447],"ADCs":[138,178,262,353],"has":[139],"demonstrated":[140,339],"more":[141,253],"wider":[142,340],"windows":[144],"than":[148,255,343],"regular":[149],"antitubulin":[150],"payloads,":[151],"maytansine":[154],"MMAE,":[156],"based":[157,194,443],"ADCs.":[158,190],"Here,":[159],"we":[160,367],"detail":[161],"discovery":[163],"analogs,":[166],"branch":[171,265,449],"hydrophilic":[172,266,450],"site-specific":[175,274,453],"conjugation":[176,275,454],"designed":[179],"widened":[183],"window":[185],"compared":[186],"Dxd-GGFG":[188],"linked":[189],"The":[191,261],"on":[195,444],"core":[197],"structure":[198],"SN-38,":[200],"wherein":[201],"hydrogen":[203],"C-11":[205],"was":[206,216],"replaced":[207,218],"fluorine,":[209],"hydroxyl":[212],"group":[213],"C-10":[215,283],"optionally":[217],"amino":[221],"or":[222,295,298,308,324],"ether":[224],"group.":[225],"Many":[226],"novel":[229,445],"were":[232,252],"single":[234],"tens":[236],"pM":[238],"IC50":[240],"potency":[241],"vitro":[243],"against":[244],"several":[245],"tested":[246],"tumor":[247,319],"lines,":[249],"some":[251,349],"potent":[254],"Exatecan":[256],"comparison":[259,332],"tests.":[260],"constructed":[263,336,352],"linkers":[267,451],"CrossConjuTM":[270],"technology":[271],"chemically":[273],"Fab":[277],"region":[278],"antibody":[281,439],"position":[284,301],"either":[289,293],"amide":[291],"bond,":[292],"bond":[294],"carbamide":[296,307],"bonds,":[297,310],"C-20":[300],"carbonate":[309],"exhibited":[311],"better":[313],"antitumor":[314],"vivo":[317],"CDX":[318],"models,":[320],"while":[321],"having":[322],"higher":[323],"similar":[325],"MTDs":[326],"mice":[328],"toxicity":[329],"study":[330],"GGFG-Dxd,":[338],"widows":[342],"that":[344],"conjugated":[345],"GGFG-Dxd.":[347],"Moreover,":[348],"can":[354,378],"overcomes":[355],"vitro-":[357],"vivo-acquired":[360],"resistance":[361],"commercial":[363],"drugs.":[365],"Herein,":[366],"showcase":[368],"our":[369],"platform":[370,442],"approach":[371],"CPT-ADC":[373],"designs":[374],"constructions":[376],"be":[379],"thereby":[380],"broadly":[381],"applicable":[382],"construction":[384],"various":[386],"CPT-ADCs":[387],"targeted":[389],"treatment":[390],"cancers.":[392],"Citation":[393],"Format:":[394],"Yuanyuan":[395],"Huang,":[396],"Hangbo":[397],"Ye,":[398],"Qingliang":[399],"Yang,":[400],"Lingli":[401],"Zhang,":[402],"Huihui":[403],"Guo,":[404],"Xiaolei":[405],"Liu,":[406],"Wenjun":[407],"Li,":[408],"Lu":[409],"Bai,":[410],"Junxiang":[411],"Jia,":[412],"Juan":[413],"Wang,":[414],"Xiangfei":[415],"Kong,":[416],"Jun":[417],"Zheng,":[418],"Yifang":[419],"Xu,":[420],"Gengxiang":[421],"Zhao,":[422,424,428],"Linyao":[423],"Xiang":[425],"Cai,":[426],"Ziyu":[427],"Hui":[429],"Xia,":[430],"Xia":[431],"Zhou,":[432,434],"You":[433],"Robert":[435],"Y.":[436],"Zhao.":[437],"An":[438],"drug":[440],"conjugate":[441],"[abstract].":[455],"In:":[456],"Proceedings":[457],"American":[460],"Association":[461],"Cancer":[463,481],"Research":[464],"Annual":[465],"Meeting":[466],"2024;":[467],"Part":[468],"1":[469],"(Regular":[470],"Abstracts);":[471],"2024":[472],"Apr":[473],"5-10;":[474],"San":[475],"Diego,":[476],"CA.":[477],"Philadelphia":[478],"(PA):":[479],"AACR;":[480],"Res":[482],"2024;84(6_Suppl):Abstract":[483],"nr":[484],"5820.":[485]},"counts_by_year":[],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2024-03-23T00:00:00"}